Global Cancer Tumor Profiling Market Size, Status and Forecast 2020-2026

Global Cancer Tumor Profiling Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Tumor Profiling Revenue
1.4 Market by Type
1.4.1 Global Cancer Tumor Profiling Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Next-generation Sequencing (NGS)
1.4.3 Polymerase Chain Reaction (PCR)
1.4.4 Immunohistochemistry (IHC)
1.4.5 In Situ Hybridization (ISH)
1.4.6 Microarray
1.4.7 Others
1.5 Market by Application
1.5.1 Global Cancer Tumor Profiling Market Share by Application: 2020 VS 2026
1.5.2 Personalized Medicine
1.5.3 Diagnostics
1.5.4 Biomarker Discovery
1.5.5 Prognostics
1.5.6 Research Applications
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cancer Tumor Profiling Market Perspective (2015-2026)
2.2 Global Cancer Tumor Profiling Growth Trends by Regions
2.2.1 Cancer Tumor Profiling Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Tumor Profiling Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Tumor Profiling Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Cancer Tumor Profiling Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Tumor Profiling Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cancer Tumor Profiling Players by Market Size
3.1.1 Global Top Cancer Tumor Profiling Players by Revenue (2015-2020)
3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Tumor Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Tumor Profiling Market Concentration Ratio
3.2.1 Global Cancer Tumor Profiling Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Tumor Profiling Revenue in 2019
3.3 Cancer Tumor Profiling Key Players Head office and Area Served
3.4 Key Players Cancer Tumor Profiling Product Solution and Service
3.5 Date of Enter into Cancer Tumor Profiling Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Tumor Profiling Historic Market Size by Type (2015-2020)
4.2 Global Cancer Tumor Profiling Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cancer Tumor Profiling Market Size by Application (2015-2020)
5.2 Global Cancer Tumor Profiling Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cancer Tumor Profiling Market Size (2015-2020)
6.2 Cancer Tumor Profiling Key Players in North America (2019-2020)
6.3 North America Cancer Tumor Profiling Market Size by Type (2015-2020)
6.4 North America Cancer Tumor Profiling Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cancer Tumor Profiling Market Size (2015-2020)
7.2 Cancer Tumor Profiling Key Players in Europe (2019-2020)
7.3 Europe Cancer Tumor Profiling Market Size by Type (2015-2020)
7.4 Europe Cancer Tumor Profiling Market Size by Application (2015-2020)
8 China
8.1 China Cancer Tumor Profiling Market Size (2015-2020)
8.2 Cancer Tumor Profiling Key Players in China (2019-2020)
8.3 China Cancer Tumor Profiling Market Size by Type (2015-2020)
8.4 China Cancer Tumor Profiling Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cancer Tumor Profiling Market Size (2015-2020)
9.2 Cancer Tumor Profiling Key Players in Japan (2019-2020)
9.3 Japan Cancer Tumor Profiling Market Size by Type (2015-2020)
9.4 Japan Cancer Tumor Profiling Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cancer Tumor Profiling Market Size (2015-2020)
10.2 Cancer Tumor Profiling Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Tumor Profiling Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Tumor Profiling Market Size by Application (2015-2020)
11 India
11.1 India Cancer Tumor Profiling Market Size (2015-2020)
11.2 Cancer Tumor Profiling Key Players in India (2019-2020)
11.3 India Cancer Tumor Profiling Market Size by Type (2015-2020)
11.4 India Cancer Tumor Profiling Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cancer Tumor Profiling Market Size (2015-2020)
12.2 Cancer Tumor Profiling Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Tumor Profiling Market Size by Type (2015-2020)
12.4 Central & South America Cancer Tumor Profiling Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Qiagen N.V.
13.1.1 Qiagen N.V. Company Details
13.1.2 Qiagen N.V. Business Overview
13.1.3 Qiagen N.V. Cancer Tumor Profiling Introduction
13.1.4 Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2015-2020))
13.1.5 Qiagen N.V. Recent Development
13.2 Roche Molecular Systems Inc.
13.2.1 Roche Molecular Systems Inc. Company Details
13.2.2 Roche Molecular Systems Inc. Business Overview
13.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Introduction
13.2.4 Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
13.2.5 Roche Molecular Systems Inc. Recent Development
13.3 Abott Molecular
13.3.1 Abott Molecular Company Details
13.3.2 Abott Molecular Business Overview
13.3.3 Abott Molecular Cancer Tumor Profiling Introduction
13.3.4 Abott Molecular Revenue in Cancer Tumor Profiling Business (2015-2020)
13.3.5 Abott Molecular Recent Development
13.4 Illumina Inc.
13.4.1 Illumina Inc. Company Details
13.4.2 Illumina Inc. Business Overview
13.4.3 Illumina Inc. Cancer Tumor Profiling Introduction
13.4.4 Illumina Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
13.4.5 Illumina Inc. Recent Development
13.5 NeoGenomics Laboratories
13.5.1 NeoGenomics Laboratories Company Details
13.5.2 NeoGenomics Laboratories Business Overview
13.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Introduction
13.5.4 NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2015-2020)
13.5.5 NeoGenomics Laboratories Recent Development
13.6 HTG Molecular Diagnostic
13.6.1 HTG Molecular Diagnostic Company Details
13.6.2 HTG Molecular Diagnostic Business Overview
13.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Introduction
13.6.4 HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2015-2020)
13.6.5 HTG Molecular Diagnostic Recent Development
13.7 Genomic Health Inc.
13.7.1 Genomic Health Inc. Company Details
13.7.2 Genomic Health Inc. Business Overview
13.7.3 Genomic Health Inc. Cancer Tumor Profiling Introduction
13.7.4 Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
13.7.5 Genomic Health Inc. Recent Development
13.8 Hologic Gen-Probe
13.8.1 Hologic Gen-Probe Company Details
13.8.2 Hologic Gen-Probe Business Overview
13.8.3 Hologic Gen-Probe Cancer Tumor Profiling Introduction
13.8.4 Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2015-2020)
13.8.5 Hologic Gen-Probe Recent Development
13.9 BD Biosciences
13.9.1 BD Biosciences Company Details
13.9.2 BD Biosciences Business Overview
13.9.3 BD Biosciences Cancer Tumor Profiling Introduction
13.9.4 BD Biosciences Revenue in Cancer Tumor Profiling Business (2015-2020)
13.9.5 BD Biosciences Recent Development
13.10 Siemens Healthineers
13.10.1 Siemens Healthineers Company Details
13.10.2 Siemens Healthineers Business Overview
13.10.3 Siemens Healthineers Cancer Tumor Profiling Introduction
13.10.4 Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2015-2020)
13.10.5 Siemens Healthineers Recent Development
13.11 Claris Life Sciences
10.11.1 Claris Life Sciences Company Details
10.11.2 Claris Life Sciences Business Overview
10.11.3 Claris Life Sciences Cancer Tumor Profiling Introduction
10.11.4 Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2015-2020)
10.11.5 Claris Life Sciences Recent Development
13.12 Personal Genome Diagnostics, Inc.
10.12.1 Personal Genome Diagnostics, Inc. Company Details
10.12.2 Personal Genome Diagnostics, Inc. Business Overview
10.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Introduction
10.12.4 Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
10.12.5 Personal Genome Diagnostics, Inc. Recent Development
13.13 Perthera, Inc.
10.13.1 Perthera, Inc. Company Details
10.13.2 Perthera, Inc. Business Overview
10.13.3 Perthera, Inc. Cancer Tumor Profiling Introduction
10.13.4 Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
10.13.5 Perthera, Inc. Recent Development
13.14 Foundation Medicine, Inc
10.14.1 Foundation Medicine, Inc Company Details
10.14.2 Foundation Medicine, Inc Business Overview
10.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Introduction
10.14.4 Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2015-2020)
10.14.5 Foundation Medicine, Inc Recent Development
13.15 V., Strand
10.15.1 V., Strand Company Details
10.15.2 V., Strand Business Overview
10.15.3 V., Strand Cancer Tumor Profiling Introduction
10.15.4 V., Strand Revenue in Cancer Tumor Profiling Business (2015-2020)
10.15.5 V., Strand Recent Development
13.16 ApoCell
10.16.1 ApoCell Company Details
10.16.2 ApoCell Business Overview
10.16.3 ApoCell Cancer Tumor Profiling Introduction
10.16.4 ApoCell Revenue in Cancer Tumor Profiling Business (2015-2020)
10.16.5 ApoCell Recent Development
13.17 Contextual Genomics
10.17.1 Contextual Genomics Company Details
10.17.2 Contextual Genomics Business Overview
10.17.3 Contextual Genomics Cancer Tumor Profiling Introduction
10.17.4 Contextual Genomics Revenue in Cancer Tumor Profiling Business (2015-2020)
10.17.5 Contextual Genomics Recent Development
13.18 Agendia
10.18.1 Agendia Company Details
10.18.2 Agendia Business Overview
10.18.3 Agendia Cancer Tumor Profiling Introduction
10.18.4 Agendia Revenue in Cancer Tumor Profiling Business (2015-2020)
10.18.5 Agendia Recent Development
13.19 GenScript
10.19.1 GenScript Company Details
10.19.2 GenScript Business Overview
10.19.3 GenScript Cancer Tumor Profiling Introduction
10.19.4 GenScript Revenue in Cancer Tumor Profiling Business (2015-2020)
10.19.5 GenScript Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Cancer Tumor Profiling Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Tumor Profiling Revenue
Table 3. Ranking of Global Top Cancer Tumor Profiling Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Tumor Profiling Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Next-generation Sequencing (NGS)
Table 6. Key Players of Polymerase Chain Reaction (PCR)
Table 7. Key Players of Immunohistochemistry (IHC)
Table 8. Key Players of In Situ Hybridization (ISH)
Table 9. Key Players of Microarray
Table 10. Key Players of Others
Table 11. Global Cancer Tumor Profiling Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Cancer Tumor Profiling Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Cancer Tumor Profiling Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Cancer Tumor Profiling Market Share by Regions (2015-2020)
Table 15. Global Cancer Tumor Profiling Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Cancer Tumor Profiling Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Cancer Tumor Profiling Market Growth Strategy
Table 21. Main Points Interviewed from Key Cancer Tumor Profiling Players
Table 22. Global Cancer Tumor Profiling Revenue by Players (2015-2020) (Million US$)
Table 23. Global Cancer Tumor Profiling Market Share by Players (2015-2020)
Table 24. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Tumor Profiling as of 2019)
Table 25. Global Cancer Tumor Profiling by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Cancer Tumor Profiling Product Solution and Service
Table 28. Date of Enter into Cancer Tumor Profiling Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Cancer Tumor Profiling Market Size by Type (2015-2020) (Million US$)
Table 31. Global Cancer Tumor Profiling Market Size Share by Type (2015-2020)
Table 32. Global Cancer Tumor Profiling Revenue Market Share by Type (2021-2026)
Table 33. Global Cancer Tumor Profiling Market Size Share by Application (2015-2020)
Table 34. Global Cancer Tumor Profiling Market Size by Application (2015-2020) (Million US$)
Table 35. Global Cancer Tumor Profiling Market Size Share by Application (2021-2026)
Table 36. North America Key Players Cancer Tumor Profiling Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Cancer Tumor Profiling Market Share (2019-2020)
Table 38. North America Cancer Tumor Profiling Market Size by Type (2015-2020) (Million US$)
Table 39. North America Cancer Tumor Profiling Market Share by Type (2015-2020)
Table 40. North America Cancer Tumor Profiling Market Size by Application (2015-2020) (Million US$)
Table 41. North America Cancer Tumor Profiling Market Share by Application (2015-2020)
Table 42. Europe Key Players Cancer Tumor Profiling Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Cancer Tumor Profiling Market Share (2019-2020)
Table 44. Europe Cancer Tumor Profiling Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Cancer Tumor Profiling Market Share by Type (2015-2020)
Table 46. Europe Cancer Tumor Profiling Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Cancer Tumor Profiling Market Share by Application (2015-2020)
Table 48. China Key Players Cancer Tumor Profiling Revenue (2019-2020) (Million US$)
Table 49. China Key Players Cancer Tumor Profiling Market Share (2019-2020)
Table 50. China Cancer Tumor Profiling Market Size by Type (2015-2020) (Million US$)
Table 51. China Cancer Tumor Profiling Market Share by Type (2015-2020)
Table 52. China Cancer Tumor Profiling Market Size by Application (2015-2020) (Million US$)
Table 53. China Cancer Tumor Profiling Market Share by Application (2015-2020)
Table 54. Japan Key Players Cancer Tumor Profiling Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Cancer Tumor Profiling Market Share (2019-2020)
Table 56. Japan Cancer Tumor Profiling Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Cancer Tumor Profiling Market Share by Type (2015-2020)
Table 58. Japan Cancer Tumor Profiling Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Cancer Tumor Profiling Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Cancer Tumor Profiling Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Cancer Tumor Profiling Market Share (2019-2020)
Table 62. Southeast Asia Cancer Tumor Profiling Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Cancer Tumor Profiling Market Share by Type (2015-2020)
Table 64. Southeast Asia Cancer Tumor Profiling Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Cancer Tumor Profiling Market Share by Application (2015-2020)
Table 66. India Key Players Cancer Tumor Profiling Revenue (2019-2020) (Million US$)
Table 67. India Key Players Cancer Tumor Profiling Market Share (2019-2020)
Table 68. India Cancer Tumor Profiling Market Size by Type (2015-2020) (Million US$)
Table 69. India Cancer Tumor Profiling Market Share by Type (2015-2020)
Table 70. India Cancer Tumor Profiling Market Size by Application (2015-2020) (Million US$)
Table 71. India Cancer Tumor Profiling Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Cancer Tumor Profiling Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Cancer Tumor Profiling Market Share (2019-2020)
Table 74. Central & South America Cancer Tumor Profiling Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Cancer Tumor Profiling Market Share by Type (2015-2020)
Table 76. Central & South America Cancer Tumor Profiling Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Cancer Tumor Profiling Market Share by Application (2015-2020)
Table 78. Qiagen N.V. Company Details
Table 79. Qiagen N.V. Business Overview
Table 80. Qiagen N.V. Product
Table 81. Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 82. Qiagen N.V. Recent Development
Table 83. Roche Molecular Systems Inc. Company Details
Table 84. Roche Molecular Systems Inc. Business Overview
Table 85. Roche Molecular Systems Inc. Product
Table 86. Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 87. Roche Molecular Systems Inc. Recent Development
Table 88. Abott Molecular Company Details
Table 89. Abott Molecular Business Overview
Table 90. Abott Molecular Product
Table 91. Abott Molecular Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 92. Abott Molecular Recent Development
Table 93. Illumina Inc. Company Details
Table 94. Illumina Inc. Business Overview
Table 95. Illumina Inc. Product
Table 96. Illumina Inc. Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 97. Illumina Inc. Recent Development
Table 98. NeoGenomics Laboratories Company Details
Table 99. NeoGenomics Laboratories Business Overview
Table 100. NeoGenomics Laboratories Product
Table 101. NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 102. NeoGenomics Laboratories Recent Development
Table 103. HTG Molecular Diagnostic Company Details
Table 104. HTG Molecular Diagnostic Business Overview
Table 105. HTG Molecular Diagnostic Product
Table 106. HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 107. HTG Molecular Diagnostic Recent Development
Table 108. Genomic Health Inc. Company Details
Table 109. Genomic Health Inc. Business Overview
Table 110. Genomic Health Inc. Product
Table 111. Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 112. Genomic Health Inc. Recent Development
Table 113. Hologic Gen-Probe Business Overview
Table 114. Hologic Gen-Probe Product
Table 115. Hologic Gen-Probe Company Details
Table 116. Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 117. Hologic Gen-Probe Recent Development
Table 118. BD Biosciences Company Details
Table 119. BD Biosciences Business Overview
Table 120. BD Biosciences Product
Table 121. BD Biosciences Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 122. BD Biosciences Recent Development
Table 123. Siemens Healthineers Company Details
Table 124. Siemens Healthineers Business Overview
Table 125. Siemens Healthineers Product
Table 126. Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 127. Siemens Healthineers Recent Development
Table 128. Claris Life Sciences Company Details
Table 129. Claris Life Sciences Business Overview
Table 130. Claris Life Sciences Product
Table 131. Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 132. Claris Life Sciences Recent Development
Table 133. Personal Genome Diagnostics, Inc. Company Details
Table 134. Personal Genome Diagnostics, Inc. Business Overview
Table 135. Personal Genome Diagnostics, Inc. Product
Table 136. Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 137. Personal Genome Diagnostics, Inc. Recent Development
Table 138. Perthera, Inc. Company Details
Table 139. Perthera, Inc. Business Overview
Table 140. Perthera, Inc. Product
Table 141. Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 142. Perthera, Inc. Recent Development
Table 143. Foundation Medicine, Inc Company Details
Table 144. Foundation Medicine, Inc Business Overview
Table 145. Foundation Medicine, Inc Product
Table 146. Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 147. Foundation Medicine, Inc Recent Development
Table 148. V., Strand Company Details
Table 149. V., Strand Business Overview
Table 150. V., Strand Product
Table 151. V., Strand Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 152. V., Strand Recent Development
Table 153. ApoCell Company Details
Table 154. ApoCell Business Overview
Table 155. ApoCell Product
Table 156. ApoCell Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 157. ApoCell Recent Development
Table 158. Contextual Genomics Company Details
Table 159. Contextual Genomics Business Overview
Table 160. Contextual Genomics Product
Table 161. Contextual Genomics Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 162. Contextual Genomics Recent Development
Table 163. Agendia Company Details
Table 164. Agendia Business Overview
Table 165. Agendia Product
Table 166. Agendia Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 167. Agendia Recent Development
Table 168. GenScript Company Details
Table 169. GenScript Business Overview
Table 170. GenScript Product
Table 171. GenScript Revenue in Cancer Tumor Profiling Business (2015-2020) (Million US$)
Table 172. GenScript Recent Development
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Tumor Profiling Market Share by Type: 2020 VS 2026
Figure 2. Next-generation Sequencing (NGS) Features
Figure 3. Polymerase Chain Reaction (PCR) Features
Figure 4. Immunohistochemistry (IHC) Features
Figure 5. In Situ Hybridization (ISH) Features
Figure 6. Microarray Features
Figure 7. Others Features
Figure 8. Global Cancer Tumor Profiling Market Share by Application: 2020 VS 2026
Figure 9. Personalized Medicine Case Studies
Figure 10. Diagnostics Case Studies
Figure 11. Biomarker Discovery Case Studies
Figure 12. Prognostics Case Studies
Figure 13. Research Applications Case Studies
Figure 14. Cancer Tumor Profiling Report Years Considered
Figure 15. Global Cancer Tumor Profiling Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Cancer Tumor Profiling Market Share by Regions: 2020 VS 2026
Figure 17. Global Cancer Tumor Profiling Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Cancer Tumor Profiling Market Share by Players in 2019
Figure 20. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Tumor Profiling as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Cancer Tumor Profiling Revenue in 2019
Figure 22. North America Cancer Tumor Profiling Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Cancer Tumor Profiling Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Cancer Tumor Profiling Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Cancer Tumor Profiling Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Cancer Tumor Profiling Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Cancer Tumor Profiling Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Cancer Tumor Profiling Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs